Cancer Research and Treatment

Cancer Research and Treatment Search

> Browse Articles > Search

Genitourinary cancer

Favorable Immunotherapy Plus Tyrosine Kinase Inhibition Outcome of Renal Cell Carcinoma Patients with Low CDK5 Expression

Xianglai Xu, Ying Wang, Zhaoyi Chen, Yanjun Zhu, Jiajun Wang, Jianming Guo

Cancer Res Treat. 2023;55(4):1321-1336. Published online April 3, 2023 DOI: https://doi.org/10.4143/crt.2022.1532

Real-World Study Evaluating Safety and Effectiveness of Axitinib in Korean Patients with Renal Cell Carcinoma after Failure of One Prior Systemic Therapy

Sang Joon Shin, Jae Lyun Lee, Tae Gyun Kwon, Byoung Young Shim, Ho Seok Chung, Sang-Hee Kim, Se Hoon Park

Cancer Res Treat. 2023;55(2):643-651. Published online November 28, 2022 DOI: https://doi.org/10.4143/crt.2022.883

Crossref 1

PD-L1 Upregulation by the mTOR Pathway in VEGFR-TKI–Resistant Metastatic Clear Cell Renal Cell Carcinoma

Se Un Jeong, Hee Sang Hwang, Ja-Min Park, Sun Young Yoon, Su-Jin Shin, Heounjeong Go, Jae-Lyun Lee, Gowun Jeong, Yong Mee Cho

Cancer Res Treat. 2023;55(1):231-244. Published online March 2, 2022 DOI: https://doi.org/10.4143/crt.2021.1526

Crossref 3

Risk Factors and Patterns of Locoregional Recurrence after Radical Nephrectomy for Locally Advanced Renal Cell Carcinoma

Gyu Sang Yoo, Won Park, Hongryull Pyo, Byong Chang Jeong, Hwang Gyun Jeon, Minyong Kang, Seong Il Seo, Seong Soo Jeon, Hyun Moo Lee, Han Yong Choi, Byung Kwan Park, Chan Kyo Kim, Sung Yoon Park, Ghee Young Kwon

Cancer Res Treat. 2022;54(1):218-225. Published online April 15, 2021 DOI: https://doi.org/10.4143/crt.2020.1373

Web of Science 2 Crossref 2

Genitourinary Cancer

Ferroportin and FBXL5 as Prognostic Markers in Advanced Stage Clear Cell Renal Cell Carcinoma

Cheol Keun Park, Jayoon Heo, Won Sik Ham, Young-Deuk Choi, Sang Joon Shin, Nam Hoon Cho

Cancer Res Treat. 2021;53(4):1174-1183. Published online March 17, 2021 DOI: https://doi.org/10.4143/crt.2021.031

Web of Science 3 Crossref 2

Temsirolimus in Asian Metastatic/Recurrent Non-clear Cell Renal Carcinoma

Jii Bum Lee, Hyung Soon Park, Sejung Park, Hyo Jin Lee, Kyung A Kwon, Young Jin Choi, Yu Jung Kim, Chung Mo Nam, Nam Hoon Cho, Beodeul Kang, Hyun Cheol Chung, Sun Young Rha

Cancer Res Treat. 2019;51(4):1578-1588. Published online April 16, 2019 DOI: https://doi.org/10.4143/crt.2018.671

Web of Science 4 Crossref 4

Bevacizumab Plus Erlotinib Combination Therapy for Advanced Hereditary Leiomyomatosis and Renal Cell Carcinoma-Associated Renal Cell Carcinoma: A Multicenter Retrospective Analysis in Korean Patients

Yeonjoo Choi, Bhumsuk Keam, Miso Kim, Shinkyo Yoon, Dalyong Kim, Jong Gwon Choi, Ja Young Seo, Inkeun Park, Jae Lyun Lee

Cancer Res Treat. 2019;51(4):1549-1556. Published online March 25, 2019 DOI: https://doi.org/10.4143/crt.2019.086

Web of Science 32 Crossref 34

Application of the International Metastatic Renal Cell Carcinoma Database Consortium and Memorial Sloan Kettering Cancer Center Risk Models in Patients with Metastatic Non-Clear Cell Renal Cell Carcinoma: A Multi-Institutional Retrospective Study Using the Korean Metastatic Renal Cell Carcinoma Registry

Jung Kwon Kim, Sung Han Kim, Mi Kyung Song, Jungnam Joo, Seong Il Seo, Cheol Kwak, Chang Wook Jeong, Cheryn Song, Eu Chang Hwang, Ill Young Seo, Hakmin Lee, Sung-Hoo Hong, Jae Young Park, Jinsoo Chung, Korean Renal Cell Carcinoma Study Group

Cancer Res Treat. 2019;51(2):758-768. Published online September 7, 2018 DOI: https://doi.org/10.4143/crt.2018.421

Web of Science 9 Crossref 8

Pazopanib for the Treatment of Non-clear Cell Renal Cell Carcinoma: A Single-Arm, Open-Label, Multicenter, Phase II Study

Ki Sun Jung, Su Jin Lee, Se Hoon Park, Jae-Lyun Lee, Se-Hoon Lee, Jae Yun Lim, Jung Hun Kang, Suee Lee, Sun Young Rha, Kyung Hee Lee, Ho Young Kim, Ho Yeong Lim

Cancer Res Treat. 2018;50(2):488-494. Published online May 22, 2017 DOI: https://doi.org/10.4143/crt.2016.584

Web of Science 28 Crossref 24

Second Primary Cancer Risk among Kidney Cancer Patients in Korea: A Population-Based Cohort Study

Jae Young Joung, Whi-An Kwon, Jiwon Lim, Chang-Mo Oh, Kyu-Won Jung, Sung Han Kim, Ho Kyung Seo, Weon Seo Park, Jinsoo Chung, Kang Hyun Lee, Young-Joo Won

Cancer Res Treat. 2018;50(1):293-301. Published online April 19, 2017 DOI: https://doi.org/10.4143/crt.2016.543

Web of Science 17 Crossref 16

Incorporating Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio in Place of Neutrophil Count and Platelet Count Improves Prognostic Accuracy of the International Metastatic Renal Cell Carcinoma Database Consortium Model

Pawel Chrom, Rafal Stec, Lubomir Bodnar, Cezary Szczylik

Cancer Res Treat. 2018;50(1):103-110. Published online March 3, 2017 DOI: https://doi.org/10.4143/crt.2017.033

Web of Science 26 Crossref 28

Efficacy and Toxicity of Mammalian Target Rapamycin Inhibitors in Patients with Metastatic Renal Cell Carcinoma with Renal Insufficiency: The Korean Cancer Study Group GU 14-08

Ki Hyang Kim, Joo Hoon Kim, Ji Young Lee, Hyo Song Kim, Su Jin Heo, Ji Hyung Kim, Ho Young Kim, Sun Young Rha

Cancer Res Treat. 2016;48(4):1286-1292. Published online February 12, 2016 DOI: https://doi.org/10.4143/crt.2016.018

Web of Science 3 Crossref 4

Systemic Treatments for Metastatic Renal Cell Carcinoma: 10-Year Experience of Immunotherapy and Targeted Therapy

Sung Han Kim, Weon Seo Park, Sun Ho Kim, Jae Young Joung, Ho Kyung Seo, Kang Hyun Lee, Jinsoo Chung

Cancer Res Treat. 2016;48(3):1092-1101. Published online January 28, 2016 DOI: https://doi.org/10.4143/crt.2015.316

Web of Science 22 Crossref 23

Oncologic and Functional Outcomes after Partial Nephrectomy Versus Radical Nephrectomy in T1b Renal Cell Carcinoma: A Multicenter, Matched Case-Control Study in Korean Patients

Hoon Ah Jang, Jin Wook Kim, Seok Soo Byun, Sung Hoo Hong, Young Jun Kim, Young Hyun Park, Kyung Suk Yang, Seok Cho, Jun Cheon, Seok Ho Kang

Cancer Res Treat. 2016;48(2):612-620. Published online June 5, 2015 DOI: https://doi.org/10.4143/crt.2014.122

Web of Science 33 Crossref 31

A Case of von Hippel–Lindau Disease with Colorectal Adenocarcinoma, Renal Cell Carcinoma and Hemangioblastomas

Su Jin Heo, Choong-kun Lee, Kyu Yeon Hahn, Gyuri Kim, Hyuk Hur, Sung Hoon Choi, Kyung Seok Han, Arthur Cho, Minkyu Jung

Cancer Res Treat. 2016;48(1):409-414. Published online February 17, 2015 DOI: https://doi.org/10.4143/crt.2014.299

Web of Science 7 Crossref 7

A Study of Relationship of Atheroembolic Risk Factors with Postoperative Recovery in Renal Function after Partial Nephrectomy in Patients Staged T1-2 Renal Cell Carcinoma during Median 4-Year Follow-up

Sung Han Kim, Kyung Min Kang, Ami Yu, Jung Hoon Lee, Byung Ho Nam, Eun Sik Lee

Cancer Res Treat. 2016;48(1):288-296. Published online April 15, 2015 DOI: https://doi.org/10.4143/crt.2014.297

Web of Science 5 Crossref 3

Is there a "Trial Effect" on Outcome of Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib?

Daniel Keizman, Keren Rouvinov, Avishay Sella, Maya Gottfried, Natalie Maimon, Jenny J. Kim, Mario A. Eisenberger, Victoria Sinibaldi, Avivit Peer, Michael A. Carducci, Wilmosh Mermershtain, Raya Leibowitz-amit, Rony Weitzen, Raanan Berger

Cancer Res Treat. 2016;48(1):281-287. Published online March 5, 2015 DOI: https://doi.org/10.4143/crt.2014.289

Web of Science 8 Crossref 6

Which Patients Should We Follow up beyond 5 Years after Definitive Therapy for Localized Renal Cell Carcinoma?

Sang Hyub Lee, Hee Seo Son, Seok Cho, Sang Jin Kim, Dae Seon Yoo, Seok Ho Kang, Sung Yul Park, Jinsung Park, Sung-Goo Chang, Seung Hyun Jeon

Cancer Res Treat. 2015;47(3):489-494. Published online November 17, 2014 DOI: https://doi.org/10.4143/crt.2014.013

Web of Science 5 Crossref 3

Efficacy and Safety of Everolimus in Korean Patients with Metastatic Renal Cell Carcinoma Following Treatment Failure with a Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor

Kwonoh Park, Jae-Lyun Lee, Jin-Hee Ahn, Kyoo Hyung Lee, In-Gab Jeong, Cheryn Song, Bumsik Hong, Jun Hyuk Hong, Hanjong Ahn

Cancer Res Treat. 2014;46(4):339-347. Published online July 16, 2014 DOI: https://doi.org/10.4143/crt.2013.154

Web of Science 5 Crossref 2

Clinical Features and Treatment of Collecting Duct Carcinoma of the Kidney from the Korean Cancer Study Group Genitourinary and Gynecology Cancer Committee

Kyung A Kwon, Sung Yong Oh, Ho Young Kim, Hyo Song Kim, Ha Young Lee, Tae Min Kim, Ho Yeong Lim, Na-Ri Lee, Hyo Jin Lee, Sook Hee Hong, Sun Young Rha

Cancer Res Treat. 2014;46(2):141-147. Published online April 15, 2014 DOI: https://doi.org/10.4143/crt.2014.46.2.141

Web of Science 12 Crossref 10

Sunitinib Treatment for Metastatic Renal Cell Carcinoma in Patients with Von Hippel-Lindau Disease

Ho Cheol Kim, Jung Su Lee, Sang Hyung Kim, Hoon Sub So, Chang Yoon Woo, Jae Lyun Lee

Cancer Res Treat. 2013;45(4):349-353. Published online December 31, 2013 DOI: https://doi.org/10.4143/crt.2013.45.4.349

Web of Science 15 Crossref 14

Metastatic Renal Cell Carcinoma in a Supraclavicular Lymph Node with No Known Primary: A Case Report

Young-Rak Choi, Hye-Suk Han, Ok-Jun Lee, Sung-Nam Lim, Mi-Jin Kim, Myeong-Ho Yeon, Hyun-Jung Jeon, Ki Hyeong Lee, Seung Taik Kim

Cancer Res Treat. 2012;44(3):215-218. Published online September 30, 2012 DOI: https://doi.org/10.4143/crt.2012.44.3.215

Crossref 11

Novel Sunitinib Strategy in Metastatic Renal Cell Carcinoma on Hemodialysis: Intermittent Dose of Sunitinib after Hemodialysis

Sang Hyun Yoon, Ki Hyang Kim, Junjeong Choi, Gun Min Kim, Joo Hoon Kim, Hyo Song Kim, Young Nyun Park, Sun Young Rha

Cancer Res Treat. 2010;42(3):180-184. Published online September 30, 2010 DOI: https://doi.org/10.4143/crt.2010.42.3.180

Crossref 8

Treatment Outcomes of Sunitinib Treatment in Advanced Renal Cell Carcinoma Patients: A Single Cancer Center Experience in Korea

Min Hee Hong, Hyo Song Kim, Chan Kim, Jung Ryun Ahn, Hong Jae Chon, Sang-Joon Shin, Joong-Bae Ahn, Hyun Cheol Chung, Sun Young Rha

Cancer Res Treat. 2009;41(2):67-72. Published online June 30, 2009 DOI: https://doi.org/10.4143/crt.2009.41.2.67

Crossref 56

A Matched-cohort Comparison of Laparoscopic Renal Cryoablation using Ultra-thin Cryoprobes with Open Partial Nephrectomy for the Treatment of Small Renal Cell Carcinoma

Young Hwii Ko, Hong Seok Park, Du Geon Moon, Jeong Gu Lee, Je Jong Kim, Duck Ki Yoon, Seok Ho Kang, Jun Cheon

Cancer Res Treat. 2008;40(4):184-189. Published online December 31, 2008 DOI: https://doi.org/10.4143/crt.2008.40.4.184

Crossref 12

A Case of Multiple Intussusceptions in the Small Intestine Caused by Metastatic Renal Cell Carcinoma

Wan Kyu Eo, Gou Young Kim, Sung Il Choi

Cancer Res Treat. 2008;40(2):97-99. Published online June 30, 2008 DOI: https://doi.org/10.4143/crt.2008.40.2.97

Crossref 13

Apoptosis in Renal Cell Carcinoma: Correlation to Apoptosis Related Genes and Cell Proliferation, and Its Prognostic Significance

Ji Shin Lee, Jong Jae Jung, Sung Taek Lee, Chang Soo Park

J Korean Cancer Assoc. 2001;33(1):9-15.

Correlation between Genetic Polymorphism of CYP2D6 and CYP1A1 and Susceptibility of Renal Cell Carcinoma in Korean

Kyu Wook Park, Se Il Jung, Gyung Woo Jung, Heon Young Kwon, Jin Sook Jeong, Jin Ho Chun, Jin Han Yoon

J Korean Cancer Assoc. 2000;32(4):801-809.

The Effect of Immunotherapy Based on Interferon - alpha in Advanced Renal Cell Carcinoma

Seung Hyun Jeon, Sung Goo Chang

J Korean Cancer Assoc. 1999;31(5):986-994.

Comparison of Rb and p53 Protein Expression with Stage and Grade as a Prognostic Value in Renal Cell Carcinoma

Hye Jeong Choi, Mi Jin Ko, Mi Jin Kim, Dong Sug Kim

J Korean Cancer Assoc. 1999;31(5):979-985.